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Abstract
Rationale:Mesenteric venous thrombosis is an uncommon but potentially fatal condition that can cause bowel ischemia. It results
from a systemic hypercoagulable state or abdominal infection draining into the portal venous system. Several cases regarding
portomesenteric venous thrombosis as a complication of appendicitis were reported in adults, but there are far fewer reports in
pediatric patients. The mortality rate of the condition is high if untreated, especially in children, reaching up to 50%.
Patient concerns: A healthy 15-year-old male with no significant past medical history presented with right lower quadrant pain,
lethargy, and fever. The computed tomography scan showed a focal thrombosis at the superior mesenteric vein branch and an
inflamed appendix.
Diagnoses: Mesenteric venous thrombosis complicating acute appendicitis.
Interventions: Intravenous antibiotics along with anticoagulants and laparoscopic appendectomy
Outcomes: After 1 month, a follow-up ultrasonography revealed full resolution of the thrombosis.
Lessons: Appendicitis is one of the most frequently encountered causes of pediatric surgical emergencies; therefore, physicians
should be conscious of mesenteric venous thrombosis as a possible complication of acute appendicitis, irrespective of whether
patients have thrombophilic conditions or not.
Abbreviations: aPTT = activated partial thromboplastin time, CT = computed tomography, DVT = deep vein thrombosis, INR =
international normalized ratio, NOACs = non-vitamin K antagonist oral anticoagulants, RLQ = right lower quadrant, SMV = superior
mesenteric vein.
Keywords: adolescent, appendicitis, complication, mesenteric venous thrombosis, superior mesenteric vein thrombosis1. Introduction
Mesenteric venous thrombosis is a rare cause of bowel ischemia,
resulting from abdominal infection draining into the portal
venous system (in diverticulitis, appendicitis, and cholecystitis),
or in systemic prothrombotic states (smoking, obesity, hyperten-
sion, immobilization, surgery, trauma, oral contraceptives,
pregnancy, deficiencies of coagulation factors, cancer, etc.).[1–4]Editor: N/A.
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1The diagnosis is frequently delayed because the presenting
symptoms and physical examination and laboratory features are
usually subtle and non-specific.[5,6] The overall incidence of
mesenteric venous thrombosis is estimated at 1 in 1000
emergency department admissions and accounts for 6% to 9%
of all acute mesenteric ischemic events.[1,7]
There have been several reports regarding portomesenteric
venous thrombosis as a complication of appendicitis in adults,
but there are far fewer reports in children and adolescents. The
mortality rate of the condition is high if untreated, especially in
children, reaching up to 50%.[8,9] Therefore, it is crucial for
physicians to notice a mesenteric venous thrombosis as a possible
complication of acute appendicitis, which is one of the most
common surgical emergencies in pediatric patients.
Here we present a case of mesenteric venous thrombosis
complicating acute appendicitis in a previously healthy adoles-
cent and we also review the literature of the clinical features,
management, and outcomes of the condition in pediatric patients.
This study was approved by the Institutional Review Board of the
Yonsei University Severance Hospital. Verbal informed consent
was obtained from the patient for publication of the case details
and the accompanying images. The verbal consent has been
documented and will be made available on request.
2. Case presentation
A healthy 15-year-old male with no significant past medical
history presented to the ED with a 2-day history of right lower
quadrant (RLQ) pain, lethargy, and 1 day of fever. He had no
AB
Figure 1. Computed tomography scan demonstrated a focal thrombotic
occlusion of the superior mesenteric branch without associated bowel change
(A)(B) (see arrow).
Yoon et al. Medicine (2019) 98:48 Medicineknown allergies. He was not taking any prescribed medications
and denied cigarette smoking and use of alcohol. There was no
family history of bleeding or clotting disorders.
At presentation, his vital signs included a temperature of
37.0°C, a pulse rate 98beats/minute, a respiratory rate 16
breaths/minute, and a blood pressure of 109/57 mm Hg. On
physical exam, there was significant RLQ tenderness without
rebound tenderness, rigidity, or muscle guarding. Laboratory
tests showed an elevated white blood cell count of 14,130/ml
(neutrophils 95.4%), an aspartate aminotransferase level of 52
IU/L, a total bilirubin level of 2.2mg/dl and a direct bilirubin level
of 0.8mg/dl, a high C-reactive protein level of 136.8mg/L, a
prolonged prothrombin time of 17.5 seconds (international
normalized ratio [INR] 1.56), and an activated partial thrombo-
plastin time (aPTT) of 33.5 seconds. Other laboratory test results
were unremarkable.
The computed tomography (CT) scan showed a focal
thrombosis at the superior mesenteric vein (SMV) branch with
patent distal and proximal flowwithout abnormal bowel changes
(Fig. 1). Focal fluid distension at the appendix tip and aeration at
the proximal portion of appendix was noted (Fig. 2). Otherwise
the small and large bowel loops were not remarkable.
Additional coagulation tests were performed for measuring his
coagulability status and then anticoagulation therapy with
intravenous heparin was immediately started. The test results
showed an elevated D-dimer level (963mg/ml, normal 0–243)
and low protein C activity (46%, normal 70–130). Other tests
including protein S activity (64%, normal 62–154), fibrinogen
functional level (382mg/dl, normal 200–400), and antithrombin
III level (84%, normal 80–120) were within their normal ranges.
The patient received consultation from the Department of
Hematology as prolonged INR with decreased protein C activity
were thought to be a manifestation of non-overt disseminated
intravascular coagulation from the intra-abdominal infection.
After obtaining a blood culture, we also started intravenous
antibiotics (ceftriaxone and metronidazole).
The patient’s RLQ pain did not improve over the next 2 days;
therefore, he was referred to the Pediatric Surgery Department
and underwent laparoscopic appendectomy. The appendix was
noted as being inflamed and swollen. There was no evidence of
ischemic change of the intestine or active bleeding. Micro-
organisms were not found in the blood culture. INR and
abnormal coagulation tests (except aPTT due to heparinization)
were normalized before discharge. On hospital day 9, the patient
was discharged without any surgical complications. Intravenous
heparin was replaced with apixaban (oral factor Xa inhibitor,
2.5mg twice daily for 3 months) at discharge. After 1 month, a
follow-up ultrasound revealed full resolution of the SMV
thrombosis.Figure 2. Focal fluid distension at the appendix tip and aeration at the proximal
portion of the appendix (see arrow).3. Discussion
We present a healthy adolescent who was diagnosed with SMV
thrombosis and appendicitis with no predisposing history. We
found 19 reports of portomesenteric vein thrombosis complicat-
ing acute appendicitis in children and adolescents from 1979 to
2016 with ages ranging from 5 to 16 years (Table 1).[2,10–26] The
time from the initial symptom to diagnosis varied from a few days
to 6 weeks. Delayed diagnosis occurred mostly due to the
nonspecific presentation or symptoms which might to be
attributed to the appendicitis itself. Concomitant thrombophilic
conditions or a predisposing history were not found in most2
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Yoon et al. Medicine (2019) 98:48 Medicinecases. Liver abscess was detected in 8 (42.1%) cases.[10,13,14,20–
22,25,26] Four cases (21.1%)[2,15,17,23] underwent delayed appen-
dectomy. The more recent half of the cases (9/19, 47.3%)[2,16,19–
24,26] were treated with anticoagulants from 3 months to 1 year.
Two cases (10.5%) were found after appendectomy due to the
vomiting[16] and RLQ pain.[18] The overall prognosis was good,
but portal hypertension with bleeding esophageal varices
occurred in 1 case,[12] and 2 cases reported that the resolution
of thrombosis was not complete at last follow-up visit.[10,26]
Laboratory tests might reveal leukocytosis, elevated liver
enzyme levels, hyperbilirubinemia, and coagulopathy, but the
results are not helpful for diagnosis, although they can be used for
identifying the thrombophilic condition.[1,27,28] In our case, the
patient’s laboratory examination revealed a mild elevation of
aspartate aminotransferase and bilirubin with coagulopathy, but
those abnormalities were normalized before discharge (aPTTwas
normalized after heparin discontinuation).
Blood and abdominal fluid cultures can be helpful in
identifying the causative microorganisms in mesenteric vein
thrombosis. In adult cases, Escherichia coli, Klebsiella pneumo-
niae, Bacteroides fragilis, Proteus mirabilis are commonly
detected causative microorganisms.[29,30] In pediatric cases, the
causative microorganisms found in 42.1% (8/19) of cases
included Bacteroides fragilis, Escherichia coli, Yersinia enter-
ocolitica, and Clostridium difficile.[10,11,15,17,19,20,22,26]Bacter-
oides fragilis was the most common isolated organism (4/8,
50.0%).[11,17,19,22,26] Physicians should consider these pathogens
when initiating empirical antibiotic therapy.
A filling defect of the vessel was found in about 90% of cases in
contrast-enhanced CT scans.[1,31] The presence of locules of air
within the SMV or portal venous system is another CT finding
suggestive of thrombosis.[32] CT is also helpful for identifying the
primary infection source and other accompanying lesions such as
a liver abscess.[32,33] Doppler ultrasonography is the first-line
study for the diagnosis of portal vein thrombosis and is mostly
useful in the follow up of these cases as it was with our case.[32,34]
Mesenteric venous thrombosis can lead to bowel ischemia or
infarction unless treated. Therefore, if mesenteric venous
thrombosis is diagnosed, adequate treatment should be promptly
initiated including surgical removal of the infection source,
broad-spectrum antibiotics, and anticoagulation therapy.[1,5,35]
In our case, we immediately started heparinization and systemic
antibiotics, and we delayed surgical treatment because some
reported cases successfully recovered with interval appendecto-
my.[23] However, the abdominal pain was not relieved; therefore,
a laparoscopic appendectomy was performed.
The role and duration of anticoagulation therapy in patients
with mesenteric venous thrombosis is still controversial,[5,36] but
anticoagulation therapy is reported to lower the recurrence of
thrombosis and the mortality rate.[1,36] The recommended total
duration of anticoagulant therapy is at least 3 to 6months,[1,37,38]
although a longer duration is suggested if a thrombophilic
condition is identified.[39] In our case, the patient received
intravenous unfractionated heparin during the hospital stay and
then apixaban for 3 months after discharge. He was successfully
treated without other complications or a recurrence of
thrombosis.
Apixaban, a factor Xa inhibitor, is 1 of the non-vitamin K
antagonist oral anticoagulants (NOACs), and is a safer
alternative for the prevention of venous thromboembolism than
vitamin K antagonists (e.g., warfarin) in adults.[40] NOACs do
not need specific monitoring and have fewer complications (e.g.,4a lower incidence of major bleeding) than warfarin.[38,40]
Moreover, apixaban has been reported to be effective in both
the treatment and prevention of deep vein thrombosis (DVT)
and for the postoperative prevention of DVT.[41] Although the
use of NOACs in pediatric patients has limited data, recent
studies found similar concentration-related effects between
adults and children.[42] Furthermore, clinical outcomes in adult
studies and pharmacological properties suggest that apixaban
may have particular advantages for children.[42] There are
currently several ongoing studies.[43–45] In the present case, we
prescribed apixaban because the patient was a previously
healthy adolescent and due to the risk of postoperative bleeding,
and to improve anticoagulant therapy adherence. He was
successfully treated without other complications or a recurrence
of thrombosis.4. Conclusion
Mesenteric venous thrombosis is a rare but possible complication
of acute appendicitis in previously healthy pediatric patients. Its
non-specific clinical characteristics can make an early diagnosis
difficult. Mesenteric venous thrombosis should be considered
when prolonged unexplained abdominal pain, fever, or elevated
liver enzyme levels are concomitant in a patient with appendicitis
(whether before or after surgery). Appendicitis is the most
common cause of pediatric surgical emergencies;[46] therefore,
clinical awareness and concern for mesenteric venous thrombosis
is warranted for physicians.Author contributions
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